
Vera Therapeutics Inc (VERA)
NASDAQ
Fin d'année 31 Décembre 2024 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -440.587 | -178.236 | -47.156 | -82.772 | -62.538 | -36.608 |
Return on Equity (%) | 64.868 | 84.853 | 330.117 | -121.578 | -107.496 | -44.826 |
Return on Invested Capital (%) | -765.568 | -196.917 | -55.831 | -104.183 | -80.871 | -42.931 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 11.016 | 141.487 | 3.271 | 2.766 | 2.289 | 9.114 |
Earnings Per Share | -36.814 | -150.459 | -1.533 | -3.203 | -2.16 | -2.403 |
Cash Per Share | 9.922 | 151.138 | 3.745 | 1.563 | 1.028 | 1.463 |
Working Capital Per Share | 7.78 | 146.07 | 3.518 | 3.601 | 3.37 | 9.883 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -36.811 | -150.456 | -1.533 | -3.203 | -2.16 | -2.403 |
EBITDA Per Share | -36.811 | -150.456 | -1.533 | -3.203 | -2.16 | -2.403 |
Free Cash Flow Per Share | -38.006 | -150.887 | -1.541 | -3.201 | -2.159 | -2.389 |
Fin d'année 31 Décembre 2024 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 322k | 355k | 20,97M | 27,8M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,37B |
Ratio cours/bénéfice | -8,92 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 14,65 |
Ratio prix/valeur comptable | 2,35 |
Rendement de dividende | - |
Actions en circulation | 63,75M |
Volume moyen (1 semaine) | 1,26M |
Volume moyen (1 mois) | 1,13M |
Variation sur 52 semaines | -54,51% |
Plus haut sur 52 semaines | 51,61 |
Plus bas sur 52 semaines | 18,53 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales